CC
OGN icon

Cypress Capital’s Organon & Co OGN Stock Holding History

Cypress Capital’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-25
Closed -$518 – 266
2024
Q2 		$518 Buy
+25
New +$497 ﹤0.01% 351
2021
Q3 		– Sell
-1,511
Closed -$46K – 210
2021
Q2 		$46K Buy
+1,511
New +$49.7K 0.04% 56

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DRZID
DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.96B AUM 38.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cypress Capital's OGN Position: Q3 2024 in Review

Cypress Capital sold out of Organon & Co (OGN) in Q3 2024, closing a stake of 25 shares — an estimated $518 sold.

Cypress Capital first reported a position in OGN in Q2 2021 and held it in 2 quarters. The position peaked at $46K in Q2 2021. 724 funds tracked by Wall St. Rank hold OGN as of Q3 2024.

  • Cypress Capital reported no remaining Organon & Co position as of Q3 2024 after selling out during the quarter.
  • Cypress Capital sold 25 Organon & Co shares in Q3 2024, an estimated $518.
  • Cypress Capital first reported a position in Organon & Co in Q2 2021 and held it in 2 quarters.
  • Cypress Capital's Organon & Co position peaked at $46K in Q2 2021.
  • 724 funds tracked by Wall St. Rank held Organon & Co as of Q3 2024.

Based on Cypress Capital's 13F filing for Q3 2024, filed 12 Nov 2024.